Pacific Biosciences Of California (PACB) Intangibles (2021 - 2026)

Pacific Biosciences Of California's Intangibles history runs 6 years deep, the most recent figure standing at $14.1 million for Q1 2026.

• On a quarterly basis, Intangibles fell 22.43% year-over-year to $14.1 million in Q1 2026; TTM through Mar 2026 was $14.1 million, a 22.43% decrease from a year earlier, with the FY2025 full-year figure at $15.1 million, down 96.12% from the prior year.
• Intangibles declined to $14.1 million in Q1 2026 per PACB's latest filing, from $15.1 million in the prior quarter.
• Across five years, Intangibles topped out at $461.8 million in Q3 2023 and bottomed at $14.1 million in Q1 2026.
• The 5-year median for Intangibles is $410.2 million (2022), against an average of $304.7 million.
• Across the five-year window, Intangibles rose 12.56% in 2023 and slumped 96.3% in 2025, its largest moves.
• Year by year, Intangibles stood at $410.2 million in 2022, then rose by 11.39% to $457.0 million in 2023, then slipped by 14.75% to $389.6 million in 2024, then tumbled by 96.12% to $15.1 million in 2025, then slipped by 6.74% to $14.1 million in 2026.
• Per Business Quant, the three latest PACB Intangibles figures stand at $14.1 million (Q1 2026), $15.1 million (Q4 2025), and $16.1 million (Q3 2025).